Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection

Clinical trials evaluating the safety and efficacy of daclatasvir for chronic hepatitis C virus (HCV) genotype 4 infection are scarce and yet with small sample sizes. Therefore, we conducted this systematic review to investigate the efficacy of daclatasvir in HCV genotype 4 treatment. A computer lit...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gadelkarim, Arwa Mohamed, Mohamed Gabr, Ahmed Negida
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Bangladesh Pharmacological Society 2017-03-01
Edice:	Bangladesh Journal of Pharmacology
Témata:	Daclatasvir Hepatitis C Interferon Ribavirin Meta-analysis
On-line přístup:	https://www.banglajol.info/index.php/BJP/article/view/29940
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!